Role of Copper Efflux in Pneumococcal Pathogenesis and Resistance to Macrophage-mediated Immune Clearance
Overview
Authors
Affiliations
In bacteria, the intracellular levels of metals are mediated by tightly controlled acquisition and efflux systems. This is particularly true of copper, a trace element that is universally toxic in excess. During infection, the toxic properties of copper are exploited by the mammalian host to facilitate bacterial clearance. To better understand the role of copper during infection, we characterized the contribution of the cop operon to copper homeostasis and virulence in Streptococcus pneumoniae. Deletion of either the exporter, encoded by copA, or the chaperone, encoded by cupA, led to hypersensitivity to copper stress. We further demonstrated that loss of the copper exporter encoded by copA led to decreased virulence in pulmonary, intraperitoneal, and intravenous models of infection. Deletion of copA resulted in enhanced macrophage-mediated bacterial clearance in vitro. The attenuation phenotype of the copA mutant in the lung was found to be dependent on pulmonary macrophages, underscoring the importance of copper efflux in evading immune defenses. Overall, these data provide insight into the role of the cop operon in pneumococcal pathogenesis.
Definition of the effector landscape across 13 phytoplasma proteomes with LEAPH and EffectorComb.
Calia G, Cestaro A, Schuler H, Janik K, Donati C, Moser M NAR Genom Bioinform. 2024; 6(3):lqae087.
PMID: 39081684 PMC: 11287381. DOI: 10.1093/nargab/lqae087.
Copper homeostasis dysregulation in respiratory diseases: a review of current knowledge.
Song W, Yue Y, Zhang Q, Wang X Front Physiol. 2024; 15:1243629.
PMID: 38883186 PMC: 11176810. DOI: 10.3389/fphys.2024.1243629.
Determinants of bacterial survival and proliferation in blood.
Le-Bury P, Echenique-Rivera H, Pizarro-Cerda J, Dussurget O FEMS Microbiol Rev. 2024; 48(3).
PMID: 38734892 PMC: 11163986. DOI: 10.1093/femsre/fuae013.
Improved diagnostic markers for invasive pulmonary aspergillosis in COPD patients.
Long Z, Li X, Li Z, Hu J, Qiu Y, Li S Front Cell Infect Microbiol. 2024; 14:1294971.
PMID: 38633749 PMC: 11021593. DOI: 10.3389/fcimb.2024.1294971.
Zhou Y, Zhang L Front Cell Infect Microbiol. 2023; 13:1267931.
PMID: 38106478 PMC: 10723777. DOI: 10.3389/fcimb.2023.1267931.